BIn the 1990s, scientist Lotte Bjerre Knudsen was tasked with revitalizing a struggling program at Novo Nordisk that was attempting to harness the newly discovered hormone GLP-1 into viable drug candidates for diabetes. At the time, many Knudsens executives had already lost hope in this program. After all, Novos focused on insulin, and the natural …
Weight loss medications have grown in popularity in recent years. People even use a drug like Ozempic, although it is only approved for diabetes, simply because it helps them lose weight. In the last three months of 2022 alone, more than 9 million prescriptions for weight loss drugs were dispensed in the United States. In …
Wegovy injection pens Michael Siluk/UCG/Universal Images Group via Getty Images At a health care conference, executives debated whether employers should pay for workers’ weight-loss drugs. A Blackstone executive warned that expensive GLP-1 drugs could put some employers out of business. Panelists agreed that companies covering drugs should do so as part of a broader support …
Continuing shortages of a popular diabetes drug used off-label for weight loss means some diabetic Calgarians are having to go without it, while others are seeking extra supplies. The 1 mg pen dose of Ozempic, a prescription drug approved in Canada to treat adult patients with type 2 diabetes mellitus, has been in short supply …